Voxelotor Can Promote Long-Term Benefits in Teens, Adults with SCD, Latest Clinical Data Show
News
Global Blood Therapeutics’ lead therapeutic candidate voxelotor can induce rapid, robust, and sustained improvements in the amount of hemoglobin in adolescents and adults with sickle cell disease (SCD), according ... Read more